Nordion's shareholders have signed off on the previously announced sale of the company to sterilization services vendor Sterigenics for $13 per share in cash.
The resolution to authorize the plan required a two-thirds vote from Nordion's shareholders. The deal is contingent upon Nordion having at closing approximately $300 million (U.S.) in cash, and it is expected to close in the second half of 2014.
